Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Pegmolesatide in Renal Anemia: Efficacy and Safety of Switching to Pegmolesatide in Non-dialysis CKD Patients Treated With rhuEPO or HIF-PHI

NCT06946394 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Dalian Medical University as lead sponsor.

NCT NCT06946394
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06946394 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Pegmolesatide in Renal Anemia: Efficacy and Safety of Switching to Pegmolesatide in Non-dialysis CKD Patients Treated With rhuEPO or HIF-PHI
Lead sponsor
The First Affiliated Hospital of Dalian Medical University
Phase
Phase 4
Overall status
Recruiting
Start date
May 1, 2025
Completion date
December 31, 2027
Enrollment
160 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal anemia in non-dialysis chronic kidney disease